{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2000-D-0187\" sorted by posted_date descending", "rows": [["FDA-2000-D-0187-0052", "FDA", "FDA-2000-D-0187", "Reference 5 - Malaria _ CDC Yellow Book 2024", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:55:21Z", null, 0, 0, "09000064868c15dc"], ["FDA-2000-D-0187-0057", "FDA", "FDA-2000-D-0187", "Reference 10 - Mungai M", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:56:15Z", null, 0, 0, "09000064868c15e1"], ["FDA-2000-D-0187-0053", "FDA", "FDA-2000-D-0187", "Reference 6 - Local Transmission of I Plasmodium vivax I Malaria --- Palm Beach County Florida 2003", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:55:34Z", null, 0, 0, "09000064868c15dd"], ["FDA-2000-D-0187-0065", "FDA", "FDA-2000-D-0187", "Reference 18 - Khan J", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:57:36Z", null, 0, 0, "09000064868c15f5"], ["FDA-2000-D-0187-0072", "FDA", "FDA-2000-D-0187", "Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria; Draft Guidance for Industry", "Other", "Guidance", "2025-01-16T05:00:00Z", 2025, 1, "2025-01-16T05:00:00Z", "2025-03-18T03:59:59Z", "2025-03-22T01:00:44Z", null, 1, 0, "09000064868c694a"], ["FDA-2000-D-0187-0050", "FDA", "FDA-2000-D-0187", "Reference 3 - Doolan D", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:55:01Z", null, 0, 0, "09000064868c156b"], ["FDA-2000-D-0187-0062", "FDA", "FDA-2000-D-0187", "Reference 15 - Stubbs L", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:57:09Z", null, 0, 0, "09000064868c15f2"], ["FDA-2000-D-0187-0064", "FDA", "FDA-2000-D-0187", "Reference 17 - Dike A", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:57:27Z", null, 0, 0, "09000064868c15f4"], ["FDA-2000-D-0187-0056", "FDA", "FDA-2000-D-0187", "Reference 9 - Muneer A", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:56:04Z", null, 0, 0, "09000064868c15e0"], ["FDA-2000-D-0187-0049", "FDA", "FDA-2000-D-0187", "Reference 2 - World Malaria Report 2022", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:54:49Z", null, 0, 0, "09000064868c156a"], ["FDA-2000-D-0187-0070", "FDA", "FDA-2000-D-0187", "Reference 23 Malaria Surveillance United States 2016 MMWR", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:58:21Z", null, 0, 0, "09000064868c161c"], ["FDA-2000-D-0187-0051", "FDA", "FDA-2000-D-0187", "Reference 4 - Mace K", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:55:11Z", null, 0, 0, "09000064868c15db"], ["FDA-2000-D-0187-0059", "FDA", "FDA-2000-D-0187", "Reference 12 - Uneke C", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:56:37Z", null, 0, 0, "09000064868c15e3"], ["FDA-2000-D-0187-0063", "FDA", "FDA-2000-D-0187", "Reference 16 - Neiderhauer C", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:57:18Z", null, 0, 0, "09000064868c15f3"], ["FDA-2000-D-0187-0061", "FDA", "FDA-2000-D-0187", "Reference 14 - Anand A", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:56:57Z", null, 0, 0, "09000064868c15f1"], ["FDA-2000-D-0187-0054", "FDA", "FDA-2000-D-0187", "Reference 7 - Blackburn D", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:55:44Z", null, 0, 0, "09000064868c15de"], ["FDA-2000-D-0187-0066", "FDA", "FDA-2000-D-0187", "Reference 19 - Israelyan N", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:57:46Z", null, 0, 0, "09000064868c15f6"], ["FDA-2000-D-0187-0048", "FDA", "FDA-2000-D-0187", "Reference 1 -Guidance for Industry.  Recommendations to Reduce the Risk of Transfusion-Transmitted  Malaria", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:54:30Z", null, 0, 0, "09000064868c1569"], ["FDA-2000-D-0187-0055", "FDA", "FDA-2000-D-0187", "Reference 8 - Duwell M", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:55:54Z", null, 0, 0, "09000064868c15df"], ["FDA-2000-D-0187-0071", "FDA", "FDA-2000-D-0187", "Reference-24 Malaria Surveillance United States 2017 MMWR", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:58:29Z", null, 0, 0, "09000064868c161d"], ["FDA-2000-D-0187-0069", "FDA", "FDA-2000-D-0187", "Reference 22-MalariaRBDMAnalysis_FINAL_2024-05-28", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:58:13Z", null, 0, 0, "09000064868c15f9"], ["FDA-2000-D-0187-0060", "FDA", "FDA-2000-D-0187", "Reference 13 - Katz L", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:56:49Z", null, 0, 0, "09000064868c15e4"], ["FDA-2000-D-0187-0068", "FDA", "FDA-2000-D-0187", "Reference 21- Blood Products Advisory Committee May 9..", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:58:04Z", null, 0, 0, "09000064868c15f8"], ["FDA-2000-D-0187-0067", "FDA", "FDA-2000-D-0187", "Reference 20 - cobas Malaria _ FDA", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:57:55Z", null, 0, 0, "09000064868c15f7"], ["FDA-2000-D-0187-0047", "FDA", "FDA-2000-D-0187", "References", "Supporting & Related Material", "Background Material", "2025-01-16T05:00:00Z", 2025, 1, null, null, "2025-01-16T16:54:14Z", null, 0, 0, "09000064868c1568"], ["FDA-2000-D-0187-0046", "FDA", "FDA-2000-D-0187", "Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2025-01-16T05:00:00Z", 2025, 1, "2025-01-16T05:00:00Z", null, "2025-01-24T18:59:15Z", "2025-01028", 0, 0, "09000064868c6752"], ["FDA-2000-D-0187-0058", "FDA", "FDA-2000-D-0187", "Malaria Guidance 2024-434", "Supporting & Related Material", null, "2025-01-16T00:00:00Z", 2025, 1, null, null, "2025-01-16T17:11:32Z", null, 0, 1, "09000064868c15e2"], ["FDA-2000-D-0187-0044", "FDA", "FDA-2000-D-0187", "Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria;\nGuidance for Industry; Availability", "Notice", "Notice of Availability", "2022-12-08T05:00:00Z", 2022, 12, "2022-12-08T05:00:00Z", null, "2022-12-08T15:46:19Z", "2022-26711", 0, 0, "0900006485524919"], ["FDA-2000-D-0187-0045", "FDA", "FDA-2000-D-0187", "Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria; Guidance for Industry - Final Guidance", "Other", "Guidance", "2022-12-08T05:00:00Z", 2022, 12, "2022-12-08T05:00:00Z", null, "2024-11-07T00:45:38Z", null, 1, 0, "090000648552199f"], ["FDA-2000-D-0187-0031", "FDA", "FDA-2000-D-0187", "Ref 4 Mace KE et al - MMWR 2017 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:02:06Z", null, 0, 0, "09000064846f6952"], ["FDA-2000-D-0187-0030", "FDA", "FDA-2000-D-0187", "Ref 3 - OBrien SF - Transfusion medicine reviews 2015 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:01:54Z", null, 0, 0, "09000064846f6951"], ["FDA-2000-D-0187-0043", "FDA", "FDA-2000-D-0187", "Ref 15 FDA BPAC Transcripts 111609 \nRe: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:05:11Z", null, 0, 0, "09000064846f69b0"], ["FDA-2000-D-0187-0026", "FDA", "FDA-2000-D-0187", "Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Other", "Guidance", "2020-06-17T04:00:00Z", 2020, 6, "2020-06-17T04:00:00Z", null, "2022-12-08T15:47:25Z", null, 0, 0, "09000064846f6586"], ["FDA-2000-D-0187-0027", "FDA", "FDA-2000-D-0187", "Reference List Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:00:39Z", null, 0, 0, "09000064846f658e"], ["FDA-2000-D-0187-0039", "FDA", "FDA-2000-D-0187", "Ref 11 Doolan D L et al Acquired immunity to malaria \nRe: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:04:15Z", null, 0, 0, "09000064846f69ac"], ["FDA-2000-D-0187-0033", "FDA", "FDA-2000-D-0187", "Ref 5 - Mace KE et al - MMWR 2018Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:02:37Z", null, 0, 0, "09000064846f697e"], ["FDA-2000-D-0187-0036", "FDA", "FDA-2000-D-0187", "Ref 8 - Reesink et al - Transfusion 2010 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:03:23Z", null, 0, 0, "09000064846f6981"], ["FDA-2000-D-0187-0041", "FDA", "FDA-2000-D-0187", "Ref 13 FDA Workshop Testing for malarial infections in blood donors July 12 2006 FDA Blood Products Advisory Committee Testing for malarial infections in blood donors July 13 2006", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:04:50Z", null, 0, 0, "09000064846f69ae"], ["FDA-2000-D-0187-0029", "FDA", "FDA-2000-D-0187", "Ref 2 - Mungai M et al - NEJM 2001 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:01:44Z", null, 0, 0, "09000064846f6950"], ["FDA-2000-D-0187-0035", "FDA", "FDA-2000-D-0187", "Ref 7 Spencer B et al Risk for malaria in United States donors deferred for travel to malaria endemic areas Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:03:14Z", null, 0, 0, "09000064846f6980"], ["FDA-2000-D-0187-0032", "FDA", "FDA-2000-D-0187", "Ref 5 - Mace KE et al - MMWR 2018 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:02:16Z", null, 0, 0, "09000064846f6953"], ["FDA-2000-D-0187-0034", "FDA", "FDA-2000-D-0187", "Ref 6 - Mace KE et al - MMWR 2019 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:03:00Z", null, 0, 0, "09000064846f697f"], ["FDA-2000-D-0187-0037", "FDA", "FDA-2000-D-0187", "Ref 9 - Spenser B et al - Transfusion Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:03:35Z", null, 0, 0, "09000064846f6982"], ["FDA-2000-D-0187-0042", "FDA", "FDA-2000-D-0187", "Ref 14 FDA Blood Products Advisory Committee - Sept 2008 \nRe: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:05:00Z", null, 0, 0, "09000064846f69af"], ["FDA-2000-D-0187-0038", "FDA", "FDA-2000-D-0187", "Ref 10 Liljander A et al Influences of intermittent preventive treatment and persistent multiclonal Plasmodium falciparum in-1 \nRe: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:03:48Z", null, 0, 0, "09000064846f6983"], ["FDA-2000-D-0187-0028", "FDA", "FDA-2000-D-0187", "Ref 1 - Katz LM & Spenser BR - AABB Press 2019 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:00:59Z", null, 0, 0, "09000064846f694f"], ["FDA-2000-D-0187-0025", "FDA", "FDA-2000-D-0187", "Revised Recommendations To Reduce the Risk of Transfusion-Transmitted\nMalaria; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-06-17T04:00:00Z", 2020, 6, "2020-06-17T04:00:00Z", null, "2020-06-17T13:13:25Z", "2020-13066", 0, 0, "09000064846f5e19"], ["FDA-2000-D-0187-0040", "FDA", "FDA-2000-D-0187", "Ref 12 - Nguyen ML et al - Transfusion 2013 \nRe: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria", "Supporting & Related Material", "Background Material", "2020-06-17T04:00:00Z", 2020, 6, null, null, "2020-06-17T15:04:26Z", null, 0, 0, "09000064846f69ad"], ["FDA-2000-D-0187-0024", "FDA", "FDA-2000-D-0187", "Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Guidance for Industry", "Other", "Guidance", "2020-04-03T04:00:00Z", 2020, 4, "2020-04-03T04:00:00Z", null, "2024-11-06T23:34:52Z", null, 1, 0, "0900006484485685"], ["FDA-2000-D-0187-0021", "FDA", "FDA-2000-D-0187", "Guidance for Industry:  Recommendations for Donor Questioning, Deferral, Reentry, and Product Management to Reduce the Risk of Transfusion-Transmitted Malaria; Availability", "Notice", "Notice of Availability", "2013-08-19T04:00:00Z", 2013, 8, "2013-08-19T04:00:00Z", null, "2013-08-19T14:42:09Z", "2013-19962", 0, 0, "09000064813b8a55"], ["FDA-2000-D-0187-0022", "FDA", "FDA-2000-D-0187", "Recommendations for Donor Questioning, Deferral, Reentry and Product Management to Reduce the Risk of Transfusion-Transmitted Malaria:  Guidance for Industry", "Other", "Guidance", "2013-08-01T04:00:00Z", 2013, 8, "2013-08-01T04:00:00Z", null, "2022-12-08T15:47:42Z", null, 0, 0, "09000064813b9117"], ["FDA-2000-D-0187-0003", "FDA", "FDA-2000-D-0187", "Draft Guidance for Industry Recommedations for Donor Questioning, Deferral, Reentry, and Product Management to Reduce Risk of Transfusion-Transmitted Malaria", "Other", "Guidance", "2012-07-06T04:00:00Z", 2012, 7, "2012-07-06T04:00:00Z", "2012-09-05T03:59:59Z", "2024-11-07T22:45:32Z", null, 1, 0, "090000648107d6f4"], ["FDA-2000-D-0187-0002", "FDA", "FDA-2000-D-0187", "Draft Guidance for Industry:Recommedations for Donor Questioning, Deferral, Reentry, and Product Management to Reduce Risk of Transfusion-Transmitted Malaria; Availability", "Notice", "Notice of Data Availability", "2012-07-06T04:00:00Z", 2012, 7, "2012-07-06T04:00:00Z", "2012-09-05T03:59:59Z", "2012-09-07T02:01:07Z", "2012-16528", 0, 0, "090000648107d34d"], ["FDA-2000-D-0187-0001", "FDA", "FDA-2000-D-0187", "FDA", "Notice", "NAD-Notice of Availability of Data", "2000-06-14T04:00:00Z", 2000, 6, "2000-06-14T04:00:00Z", "2000-09-07T03:59:59Z", "2008-04-25T01:14:48Z", null, 0, 0, "09000064804d2c71"]], "truncated": false, "filtered_table_rows_count": 54, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2000-D-0187"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2000-D-0187", "results": [{"value": "FDA", "label": "FDA", "count": 54, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2000-D-0187", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 42, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2000-D-0187", "results": [{"value": 2025, "label": 2025, "count": 27, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&posted_year=2025", "selected": false}, {"value": 2020, "label": 2020, "count": 20, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&posted_year=2020", "selected": false}, {"value": 2012, "label": 2012, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&posted_year=2012", "selected": false}, {"value": 2013, "label": 2013, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&posted_year=2013", "selected": false}, {"value": 2022, "label": 2022, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&posted_year=2022", "selected": false}, {"value": 2000, "label": 2000, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&posted_year=2000", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&_facet=comment_end_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-D-0187&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 10.462577920407057, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}